NEW YORK, Dec. 8, 2016 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced HedgePath Pharmaceuticals, Inc. (OTCQX: HPPI), a clinical stage biopharmaceutical company, has qualified to trade on the OTCQX® Best Market. HedgePath upgraded to OTCQX from the OTCQB® Venture Market.
HedgePath begins trading today on OTCQX under the symbol "HPPI." U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.
"We congratulate HedgePath Pharmaceuticals on upgrading from the OTCQB Venture Market to the family of established, investor-focused OTCQX companies," said Jason Paltrowitz, Executive Vice President of Corporate Services at OTC Markets Group. "Upgrading indicates HedgePath's commitment to high financial standards and will allow the company to expand its shareholder base and visibility in the U.S. market."
Nick Virca, CEO of HedgePath, commented, "The OTCQX market is the next logical step in our capital markets strategy as we seek to build upon our corporate milestones by generating greater visibility and credibility throughout the investment community, potentially leading to a broader base of institutional and retail investors participating in the future of our company as we look to drive stockholder value."
Ellenoff Grossman & Schole LLP serves as HedgePath's OTCQX Advisor, responsible for providing professional guidance on OTCQX requirements and U.S. securities laws.
HedgePath Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer. HedgePath's initial clinical activities are focused on seeking to repurpose the FDA approved antifungal pharmaceutical itraconazole as a potential treatment for basal cell carcinoma nevus syndrome, also known as Gorlin Syndrome.
About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates the OTCQX® Best Market, the OTCQB® Venture Market, and the Pink® Open Market for 10,000 U.S. and global securities. Through OTC Link® ATS, we connect a diverse network of broker-dealers that provide liquidity and execution services. We enable investors to easily trade through the broker of their choice and empower companies to improve the quality of information available for investors.
To learn more about how we create better informed and more efficient markets, visit www.otcmarkets.com
OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS. Subscribe to the OTC Markets RSS Feed
OTC Markets Group Inc., +1 (212) 896-4428, email@example.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/otc-markets-group-welcomes-hedgepath-pharmaceuticals-to-otcqx-300375056.html
SOURCE OTC Markets Group Inc.